4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-014259
Chief Technical Officer sold 469 shares at an average $56.40 ($26,452)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-02-12 | Sale 10b5-1 | −462 | $56.39 | $26,052 | 5,619 | D |
| Shulman Joseph Chief Technical Officer | 2025-02-12 | Sale 10b5-1 | −7 | $57.09 | $400 | 5,612 | D |
| Open-market sales · 469 sh · avg $56.40 · $26,452 | |||||||
Loading xslF345X05/tm256729-2_4seq1.xml…